Inactive Instrument

Highlights Parnell Pharmaceuticals Holdings Ltd OTC Bulletin Board

Equities

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

2022	Parnell Pharmaceuticals Holdings Ltd Reports Earnings Results for the Full Year Ended December 31, 2021	CI
2021	DW Healthcare Partners V, L.P. managed by DW Healthcare Partners completed the acquisition of a 29% stake in Parnell Pharmaceuticals Holdings Ltd (OTCPK:PARN.F) for $2.5 million	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Parnell Pharmaceuticals Holdings Ltd Reports Earnings Results for the Full Year Ended December 31, 2021	22-06-20	CI
DW Healthcare Partners V, L.P. managed by DW Healthcare Partners completed the acquisition of a 29% stake in Parnell Pharmaceuticals Holdings Ltd (OTCPK:PARN.F) for $2.5 million	21-01-27	CI
DW Healthcare Partners V, L.P. managed by DW Healthcare Partners made an offer to acquire Parnell Pharmaceuticals Holdings Ltd (OTCPK:PARN.F) for $7.2 million.	20-12-20	CI
Parnell Pharmaceuticals Announces Nomovid Antiviral Nasal Spray	20-09-23	CI
Parnell Pharmaceuticals Holdings Ltd Reports Earnings Results for the Half Year Ended June 30, 2019	19-10-13	CI
Parnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Full Year Ended 31 December 2018; Provides Earnings Guidance for the Year 2019	19-04-04	CI
Parnell Pharmaceuticals Holdings Ltd. Reports Unaudited Consolidated Earnings Results for the Nine Months Ended September 30, 2018; Revises Revenue Guidance for the Year 2018	18-11-02	CI
Parnell Pharmaceuticals Holdings Ltd. Reports Unaudited Consolidated Earnings Results for the Six Months Ended June 30, 2018; Revised Earnings Guidance for the Full Year 2018	18-08-03	CI
Parnell Pharmaceuticals Holdings Ltd Reports Audited Earnings Results for the First Quarter Ended March 31, 2018; Revises Earnings Guidance for the Year 2018	18-04-28	CI
Parnell Pharmaceuticals Holdings Ltd. Reports Unaudited Consolidated Earnings Results for the Six Months Ended June 30, 2017; Provides Earnings Guidance for the Year 2017	17-08-17	CI
Parnell Pharmaceuticals Holdings Ltd. Announces Consolidated Earnings Results for the Year Ended December 31, 2016; Provides Earnings Guidance for the Year 2017	17-03-21	CI
Parnell Pharmaceuticals Holdings Ltd. Reports Unaudited Consolidated Earnings Results for the Nine Months Ended September 30, 2016; Provides Revenue Guidance for the Full Year 2016 and 2017	16-11-02	CI
Parnell Pharmaceuticals Holdings Ltd. Reports Unaudited Consolidated Earnings Results for the Six Months Ended June 30, 2016; Provides Revenue Guidance for the Year 2016	16-08-04	CI
Parnell Pharmaceuticals Holdings Ltd Announces Contract Manufacturing Agreement with Merial	16-05-31	CI
Parnell Pharmaceuticals Holdings Ltd. Announces Consolidated Earnings Results for the Year Ended December 31, 2015; Provides Revenue Guidance for the Year 2016	16-02-23	CI
Parnell Pharmaceuticals Holdings Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2015	15-10-21	CI
Parnell Pharmaceuticals Holdings Ltd. Reports Un-Audited Earnings Results for the Six Months Ended June 30, 2015; Re-Affirm Earnings Guidance for the Fiscal Year 2015	15-08-11	CI
Parnell Pharmaceuticals Holdings Ltd Announces Positive Top-Line Pivotal Trial Results for Zydax	15-06-18	CI
Parnell Pharmaceuticals Holdings Ltd. Announces Earnings Results for the First Quarter Ended March 31, 2015	15-04-22	CI
Parnell Pharmaceuticals Holdings Ltd. Announces Unaudited Consolidated Earnings Results for the Six Months Ended December 31, 2014; Provides Revenue Guidance for Second Half of 2014 and Full Year of 2015	15-02-25	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Parnell Pharmaceuticals Holdings Ltd OTC Bulletin Board

Equities

Highlights

Filters